Statistics

Total Visits

Views
Value of serum epidermal growth factor receptor in the selection of patients with non-small-cell lung cancer to be treated with the tyrosine kinase inhibitor erlotinib5

Select a period of time:

Number of views in the range

Views
Value of serum epidermal growth factor receptor in the selection of patients with non-small-cell lung cancer to be treated with the tyrosine kinase inhibitor erlotinib5

Views

Views
November 20231
December 20230
January 20240
February 20240
March 20240
April 20240
May 20244
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
 

Top cities views

Views
Chicago3
Ashburn1